Family Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
9,943
-2,198
-18% -$254K 0.53% 41
2025
Q4
$1.28M Buy
12,141
+1,432
+13% +$134K 0.57% 36
2025
Q3
$899K Buy
10,709
+1,808
+20% +$149K 0.43% 45
2025
Q2
$705K Buy
8,901
+5,122
+136% +$407K 0.37% 48
2025
Q1
$339K Buy
3,779
+1,140
+43% +$106K 0.21% 56
2024
Q4
$263K Buy
2,639
+552
+26% +$56.9K 0.16% 58
2024
Q3
$237K Buy
2,087
+24
+1% +$2.85K 0.15% 61
2024
Q2
$255K Buy
2,063
+56
+3% +$7.21K 0.17% 57
2024
Q1
$265K Buy
2,007
+106
+6% +$13.1K 0.18% 58
2023
Q4
$207K Buy
+1,901
New +$197K 0.15% 70

Other funds holding MRK

Family Capital Management's MRK Position: Q1 2026 in Review

Family Capital Management reduced its Merck (MRK) stake by 18% in Q1 2026, selling an estimated $254K and leaving 9,943 shares worth $1.2M. The position accounts for 0.53% of the portfolio, ranked #41.

Family Capital Management first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.28M in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Family Capital Management held 9,943 shares of Merck worth $1.2M as of Q1 2026.
  • Family Capital Management sold 2,198 Merck shares in Q1 2026, an estimated $254K.
  • Merck made up 0.53% of Family Capital Management's portfolio in Q1 2026, its #41 holding.
  • Family Capital Management first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Family Capital Management's Merck position peaked at $1.28M in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Family Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.